Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey Murray

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 30, 2015
Ribavirin Reduces Absolute Lymphocyte Counts in Hepatitis C Virus-Infected Patients Treated With Interferon-Free, Direct-Acting Antiviral RegimensPatrick R Harrington, Russell Fleischer, Sarah M Connelly, et al.
Hepatology (Baltimore, Md.)|November 22, 2007
Development of novel agents for the treatment of chronic hepatitis C infection: Summary of the FDA Antiviral Products Advisory Committee recommendationsKenneth E Sherman, Russell Fleischer, Katherine Laessig, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 29, 2015
Reply to Merli et alPatrick R Harrington, Russell Fleischer, Sarah M Connelly, et al.
Journal of Virus Eradication|September 20, 2022
A systematic review of limiting antigen avidity enzyme immunoassay for detection of recent HIV-1 infection to expand supported applicationsJoseph Kin-On Lau, Nicholas Murdock, Jeffrey Murray, et al.
The Archives of Bone and Joint Surgery|June 4, 2020
Outcomes of Arthroscopic Biceps Tenodesis for the Treatment of Failed Type II SLAP Repair: A Minimum 2-Year Follow-UpAlexander Kreines, Manuel Pontes, Elizabeth Ford, et al.
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|May 14, 2020
Alphatorquevirus is the most prevalent virus identified in blood from a matched maternal-infant preterm cohortPatrick Sloan, Cynthia Rodriguez, Bruce A Bedell, et al.
AIDS (London, England)|February 4, 2012
Novel clinical trial designs for the development of new antiretroviral agentsNina Mani, Jeffrey Murray, Roy M Gulick, et al.
Journal of Virus Eradication|November 9, 2019
Sustained virological response rates with direct-acting antivirals in black subjects with HCV genotype 1 infection: systematic analysis of clinical trialsKimberly Struble, Kirk Chan-Tack, Karen Qi, et al.
Jmirx Med|March 21, 2024
Authors' Response to Peer Reviews of "Impact of the COVID-19 Pandemic on Latino Families With Alzheimer Disease and Related Dementias: Qualitative Interviews With Family Caregivers and Primary Care Providers"Jaime Perales-Puchalt, Jill Peltzer, Monica Fracachan-Cabrera, et al.
Pediatric Blood & Cancer|October 27, 2015
Risk-Based Therapy for Localized OsteosarcomaRajkumar Venkatramani, Jeffrey Murray, Lee Helman, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 30, 2015
Ribavirin Reduces Absolute Lymphocyte Counts in Hepatitis C Virus-Infected Patients Treated With Interferon-Free, Direct-Acting Antiviral RegimensPatrick R Harrington, Russell Fleischer, Sarah M Connelly, et al.
Hepatology (Baltimore, Md.)|November 22, 2007
Development of novel agents for the treatment of chronic hepatitis C infection: Summary of the FDA Antiviral Products Advisory Committee recommendationsKenneth E Sherman, Russell Fleischer, Katherine Laessig, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 29, 2015
Reply to Merli et alPatrick R Harrington, Russell Fleischer, Sarah M Connelly, et al.
Journal of Virus Eradication|September 20, 2022
A systematic review of limiting antigen avidity enzyme immunoassay for detection of recent HIV-1 infection to expand supported applicationsJoseph Kin-On Lau, Nicholas Murdock, Jeffrey Murray, et al.
The Archives of Bone and Joint Surgery|June 4, 2020
Outcomes of Arthroscopic Biceps Tenodesis for the Treatment of Failed Type II SLAP Repair: A Minimum 2-Year Follow-UpAlexander Kreines, Manuel Pontes, Elizabeth Ford, et al.
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|May 14, 2020
Alphatorquevirus is the most prevalent virus identified in blood from a matched maternal-infant preterm cohortPatrick Sloan, Cynthia Rodriguez, Bruce A Bedell, et al.
AIDS (London, England)|February 4, 2012
Novel clinical trial designs for the development of new antiretroviral agentsNina Mani, Jeffrey Murray, Roy M Gulick, et al.
Journal of Virus Eradication|November 9, 2019
Sustained virological response rates with direct-acting antivirals in black subjects with HCV genotype 1 infection: systematic analysis of clinical trialsKimberly Struble, Kirk Chan-Tack, Karen Qi, et al.
Jmirx Med|March 21, 2024
Authors' Response to Peer Reviews of "Impact of the COVID-19 Pandemic on Latino Families With Alzheimer Disease and Related Dementias: Qualitative Interviews With Family Caregivers and Primary Care Providers"Jaime Perales-Puchalt, Jill Peltzer, Monica Fracachan-Cabrera, et al.
Pediatric Blood & Cancer|October 27, 2015
Risk-Based Therapy for Localized OsteosarcomaRajkumar Venkatramani, Jeffrey Murray, Lee Helman, et al.
Pageof 5